question,category,difficulty,answer,ground_truth,citation_accuracy,retrieval_recall,refusal_appropriate,ground_truth_match,faithfulness,answer_relevancy,context_precision
What is the recommended duration of maintenance immunotherapy for patients who received front-line immunotherapy?,treatment_duration,easy,"The recommended duration of maintenance immunotherapy for patients who received front-line immunotherapy is 2 years, if tolerated (nscl.pdf, page n/a).",2 years if tolerated,1.0,1.0,1.0,0.0,1.0,1.0,0.59999999997
Which targeted therapy is preferred as first-line treatment for patients with EGFR exon 19 deletion or L858R mutations?,targeted_therapy,easy,"The preferred targeted therapy as a first-line treatment for patients with EGFR exon 19 deletion or L858R mutations is single-agent osimertinib. Other recommended first-line treatment options include single-agent erlotinib, afatinib, gefitinib, or dacomitinib (nscl.pdf, page n/a).",osimertinib,1.0,1.0,1.0,1.0,1.0,0.8864544065549388,0.5176286676200405
"What imaging studies are recommended to rule out metastatic disease in patients with T1-2, N2 disease confirmed before thoracotomy?",diagnostic_imaging,medium,"For patients with T1-2, N2 disease confirmed before thoracotomy, an initial brain MRI with contrast and FDG PET/CT scan (if not previously done) are recommended to rule out metastatic disease (nscl.pdf, page n/a).",brain MRI with contrast and FDG PET/CT scan,1.0,1.0,1.0,1.0,0.3333333333333333,0.9166125473829995,0.15758928571034597
"For patients with performance status 2 and nonsquamous NSCLC, what are the recommended single-agent chemotherapy options?",chemotherapy,medium,"For patients with performance status 2 and nonsquamous NSCLC, the recommended single-agent chemotherapy options include gemcitabine, pemetrexed, or taxanes (nscl.pdf).","gemcitabine, pemetrexed, or taxanes",1.0,1.0,1.0,1.0,1.0,0.8090373144043856,0.5499999999816666
